341 related articles for article (PubMed ID: 15094766)
1. eIF4E--from translation to transformation.
Mamane Y; Petroulakis E; Rong L; Yoshida K; Ler LW; Sonenberg N
Oncogene; 2004 Apr; 23(18):3172-9. PubMed ID: 15094766
[TBL] [Abstract][Full Text] [Related]
2. The role of translation in neoplastic transformation from a pathologist's point of view.
Rosenwald IB
Oncogene; 2004 Apr; 23(18):3230-47. PubMed ID: 15094773
[TBL] [Abstract][Full Text] [Related]
3. The role of c-myc in regulation of translation initiation.
Schmidt EV
Oncogene; 2004 Apr; 23(18):3217-21. PubMed ID: 15094771
[TBL] [Abstract][Full Text] [Related]
4. Eukaryotic initiation factor 4E variants alter the morphology, proliferation, and colony-formation properties of MDA-MB-435 cancer cells.
Goldson TM; Vielhauer G; Staub E; Miller S; Shim H; Hagedorn CH
Mol Carcinog; 2007 Jan; 46(1):71-84. PubMed ID: 17091471
[TBL] [Abstract][Full Text] [Related]
5. Translational control of malignancy: the mRNA cap-binding protein, eIF-4E, as a central regulator of tumor formation, growth, invasion and metastasis.
Zimmer SG; DeBenedetti A; Graff JR
Anticancer Res; 2000; 20(3A):1343-51. PubMed ID: 10928042
[TBL] [Abstract][Full Text] [Related]
6. Targeting the eukaryotic translation initiation factor 4E for cancer therapy.
Graff JR; Konicek BW; Carter JH; Marcusson EG
Cancer Res; 2008 Feb; 68(3):631-4. PubMed ID: 18245460
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of the eukaryotic translation initiation factor eIF4E contributes to its transformation and mRNA transport activities.
Topisirovic I; Ruiz-Gutierrez M; Borden KL
Cancer Res; 2004 Dec; 64(23):8639-42. PubMed ID: 15574771
[TBL] [Abstract][Full Text] [Related]
8. The role of eIF4 in cell proliferation.
Flynn A; Proud CG
Cancer Surv; 1996; 27():293-310. PubMed ID: 8909806
[TBL] [Abstract][Full Text] [Related]
9. eIF-4E expression and its role in malignancies and metastases.
De Benedetti A; Graff JR
Oncogene; 2004 Apr; 23(18):3189-99. PubMed ID: 15094768
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide in physiologic concentrations targets the translational machinery to increase the proliferation of human breast cancer cells: involvement of mammalian target of rapamycin/eIF4E pathway.
Pervin S; Singh R; Hernandez E; Wu G; Chaudhuri G
Cancer Res; 2007 Jan; 67(1):289-99. PubMed ID: 17210710
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Myc-dependent apoptosis by eukaryotic translation initiation factor 4E requires cyclin D1.
Tan A; Bitterman P; Sonenberg N; Peterson M; Polunovsky V
Oncogene; 2000 Mar; 19(11):1437-47. PubMed ID: 10723135
[TBL] [Abstract][Full Text] [Related]
12. Expression levels of eIF4E, VEGF, and cyclin D1, and correlation of eIF4E with VEGF and cyclin D1 in multi-tumor tissue microarray.
Yang SX; Hewitt SM; Steinberg SM; Liewehr DJ; Swain SM
Oncol Rep; 2007 Feb; 17(2):281-7. PubMed ID: 17203162
[TBL] [Abstract][Full Text] [Related]
13. Targets and mechanisms for the regulation of translation in malignant transformation.
Clemens MJ
Oncogene; 2004 Apr; 23(18):3180-8. PubMed ID: 15094767
[TBL] [Abstract][Full Text] [Related]
14. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
[TBL] [Abstract][Full Text] [Related]
15. p53-dependent translational control of senescence and transformation via 4E-BPs.
Petroulakis E; Parsyan A; Dowling RJ; LeBacquer O; Martineau Y; Bidinosti M; Larsson O; Alain T; Rong L; Mamane Y; Paquet M; Furic L; Topisirovic I; Shahbazian D; Livingstone M; Costa-Mattioli M; Teodoro JG; Sonenberg N
Cancer Cell; 2009 Nov; 16(5):439-46. PubMed ID: 19878875
[TBL] [Abstract][Full Text] [Related]
16. Tumor suppression by IFN regulatory factor-1 is mediated by transcriptional down-regulation of cyclin D1.
Kröger A; Stirnweiss A; Pulverer JE; Klages K; Grashoff M; Reimann J; Hauser H
Cancer Res; 2007 Apr; 67(7):2972-81. PubMed ID: 17409403
[TBL] [Abstract][Full Text] [Related]
17. High affinity RNA for mammalian initiation factor 4E interferes with mRNA-cap binding and inhibits translation.
Mochizuki K; Oguro A; Ohtsu T; Sonenberg N; Nakamura Y
RNA; 2005 Jan; 11(1):77-89. PubMed ID: 15611299
[TBL] [Abstract][Full Text] [Related]
18. Translational upregulation of yes accompanies eIF4E-mediated oncogenic transformation.
Defatta RJ; De Benedetti A
Int J Oncol; 2003 Dec; 23(6):1709-13. PubMed ID: 14612945
[TBL] [Abstract][Full Text] [Related]
19. The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis.
Ruggero D; Montanaro L; Ma L; Xu W; Londei P; Cordon-Cardo C; Pandolfi PP
Nat Med; 2004 May; 10(5):484-6. PubMed ID: 15098029
[TBL] [Abstract][Full Text] [Related]
20. Signal transduction pathways leading to increased eIF4E phosphorylation caused by oxidative stress.
Duncan RF; Peterson H; Sevanian A
Free Radic Biol Med; 2005 Mar; 38(5):631-43. PubMed ID: 15683719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]